Yellow fever is a lethal flu-like disease which is instigated by Aedes aegypti mosquito. It causes damage to kidney, liver and heart and is described by a high fever and jaundice. The common symptoms of yellow fever comprise fever, headache, nausea and vomiting. In adverse cases, yellow fever disturbs some vital organs such as heart, kidney and liver.
Increasing research and development for the development of vaccines for yellow fever is estimated to boost growth of the global yellow fever treatment market throughout the forecasted period. For instance, Saint Louis University’s Center for Vaccine Development had introduced inspecting a vaccine for yellow fever in July 2021. Sanofi Pasteur subsidized this research and there is a need for increasing a new vaccine as the vaccine presently used consists of egg protein which cannot be used for individuals allergic to egg.
The global demand for market was predicted to be about USD 490 million in 2022, and by the end of 2031, existing and expected developments would hit valuations of around USD 680 million. The industry players and analysts predict the global Yellow fever treatment market growth of around 3.8% in terms of CAGR. During the forthcoming years, unhealthy lifestyle of people boosts the susceptibility of yellow fever across the world is expected to upsurge the market growth. Moreover, improving healthcare organization in developing nations and increasing awareness among the people regarding the management of yellow fever is further assessed to bolster the growth of the yellow fever treatment market. However, the factors such as inaccessibility of an actual treatment options other than vaccination and inadequate supply of vaccination to encounter the growing demand anticipated to confine the market growth rate.
Click Here to Access the Free Sample Report @ https://analyticsmarketresearch.com/sample-request/yellow-fever-treatment-market/57616/
Some of the leading and top yellow fever treatment companies in the global yellow fever treatment market include Sanofi Pasteur SA, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos among others. The leading five players such as Sanofi Pasteur SA, Pfizer Inc., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG hold around 40% market share of the global yellow fever treatment market.
On the basis of transmission type, the global yellow fever treatment market can be segmented into intermediate yellow fever, sylvatic yellow fever, urban yellow fever, and others with the ‘intermediate yellow fever’ category having the leading market share of about 27 percent, closely followed by the “sylvatic yellow fever” category at about 20 percent of the global yellow fever treatment market share. Based on medication, the yellow fever treatment market is segmented into proton pump inhibitors, antipyretics, histamine H2 antagonists, and others. On the basis of end user, the market can be segmented into hospitals, homecare, specialty clinics, and others. In terms of geography, North America region held the leading market share of around 30% among other regions such as Asia Pacific, Europe, Latin America, and Middle East & Africa in the global Yellow fever treatment market.
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005